Award,contract · Find a Tender
Sequencing Technologies in Clinical Research
Part of Sequencing Technologies in Clinical Research.
Nanopore-based sequencing has become a highly effective next generation sequencing tool for biological research. Nanopore sequencing converts the electrical signals generated by a nucleotide strand (either DNA or RNA) passing through the nanopore into the base sequence. This methodology was exclusively commercialized by Oxford Nanopore Technologies, allowing sequencing of long reads with real-time sequence detection and analysis. It can also provide base modification detection. The technique has short sample preparation times with low instrument costs. The technology is a relatively new, ra…
- Procurement
- Sequencing Technologies in Clinical Research
- Published
- 2 Dec 2024
- Status
- complete
- CPV
- 38000000 — Laboratory, optical and precision equipments (excl. glasses)
- Tender period
- —
Awards
Other notices in this procurement
This is the only notice on record.
FAQs about this notice
What type of notice is this?
This is a award,contract published via Find a Tender on 2 Dec 2024.
Which procurement does this notice belong to?
It is part of "Sequencing Technologies in Clinical Research", published by THE UNIVERSITY OF BIRMINGHAM.
Has this notice resulted in an award?
1 award is recorded on this notice, including to Oxford Nanopore Technologies.
Get the full procurement picture
Enable turns the UK's public-contract data into pipeline intelligence for bid and capture teams. Talk to us about access, alerts and tailored market analysis.
Get in touch with Enable